Переглядів 121,562
Last month, the U.S. government announced a letter of interest to provide Kodak with a $765 million loan to launch Kodak Pharmaceuticals. Under this loan, Kodak would manufacture critical pharmaceutical components that have been identified by the FDA as essential but have lapsed into chronic national shortage. But the deal is now on hold as the SEC investigates the circumstances around Kodak's disclosure of the loan.
» Subscribe to CNBC: cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC Classic: cnb.cx/SubscribeCNBCclassic
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Follow CNBC on LinkedIn: cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Instagram: cnb.cx/InstagramCNBC
#CNBC